Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.120
-0.050 (-1.58%)
Apr 17, 2026, 4:00 PM EDT - Market closed
Quantum BioPharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
18.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OSR Holdings | 2.91M |
| Traws Pharma | 2.79M |
| Lipocine | 1.98M |
| SeaStar Medical Holding | 1.23M |
| VYNE Therapeutics | 570.00K |
| Allarity Therapeutics | 320.00K |
| Vyome Holdings | 319.71K |
QNTM News
- 17 days ago - Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis - GlobeNewsWire
- 20 days ago - Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis - GlobeNewsWire
- 22 days ago - Quantum Biopharma Provides Corporate Update - GlobeNewsWire
- 22 days ago - Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status - GlobeNewsWire
- 26 days ago - Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd - GlobeNewsWire
- 4 weeks ago - Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering - GlobeNewsWire
- 5 weeks ago - Quantum BioPharma Provides Corporate Update - GlobeNewsWire
- 2 months ago - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM - PRNewsWire